
Hannah Joseph Hospital IPO
- Issue price
- ₹70
- Listing price
- ₹65
- -7.14%
- Current price
- ₹106.9
- +52.71%
- Subscribed
- 1.51x
- Issue size
- —
- Listed on
- 1 Feb 2026
IPO timeline
- Opens22 JanThu
- Closes27 JanTue
- Allotment29 JanThu
- Refunds30 JanFri
- Demat credit30 JanFri
- Listing1 FebSun
Issue details
- Price band
- ₹67 – ₹70 per share
- Issue size
- —
- Fresh issue
- Not available
- Offer for sale
- Not available
- Issue type
- Fresh capital only
- Face value
- ₹10 per share
- Lot size
- 1,500 shares
- Minimum investment
- ₹1,05,000
- Listing on
- BSE SME
- Exchange code
- HANNAH.BO · 7558
Lot size and investment
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1,500 | ₹1,05,000 |
| Retail (Max) | 1 | 1,500 | ₹1,05,000 |
| HNI (Min) | 2 | 3,000 | ₹2,10,000 |
Reservation
- QIB
- 28,46,000 shares (49.93% of the Offer)
- NII
- 8,58,000 shares (15.05% of the Offer)
- Retail
- 19,96,000 shares (35.02% of the Offer)
Allotment status
The allotment for this IPO is final. Check whether you received shares on the registrar's website using your PAN, application number or demat account (DP / Client ID).
Check allotment on Bigshare Services- 1Open the registrar's allotment page and select this IPO from the list.
- 2Enter your PAN, application number or DP / Client ID.
- 3Submit to see the number of shares allotted, if any.
- Basis of allotment
- 29 Jan 2026
- Refunds initiated
- 30 Jan 2026
- Shares credited to demat
- 30 Jan 2026
- Listing
- 1 Feb 2026
Grey market premium (GMP)
- Current GMP
- ₹2
- +3.00%
- Estimated listing price
- ₹72
- Issue price ₹70
- Highest
- ₹2
- 26 Jan
- Lowest
- ₹0
- 19 Jan
GMP by day (₹ per share)
Day-wise GMP table
| Date | GMP | Premium | Est. listing |
|---|---|---|---|
| 1 Feb 2026 | ₹2 | +3.00% | ₹72 |
| 31 Jan 2026 | ₹2 | +3.00% | ₹72 |
| 30 Jan 2026 | ₹2 | +3.00% | ₹72 |
| 29 Jan 2026 | ₹2 | +3.00% | ₹72 |
| 28 Jan 2026 | ₹2 | +3.00% | ₹72 |
| 27 Jan 2026 | ₹2 | +3.00% | ₹72 |
| 26 Jan 2026 | ₹2 | +3.00% | ₹72 |
| 23 Jan 2026 | ₹0 | — | ₹70 |
| 22 Jan 2026 | ₹0 | — | ₹70 |
| 21 Jan 2026 | ₹0 | — | ₹70 |
| 19 Jan 2026 | ₹0 | — | ₹70 |
- Kostak rate
- ₹0
- Subject to sauda
- ₹2,300
GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.
Subscription status
- QIB1.08x
- NII (HNI)1.73x
- Retail1.62x
| Category | Shares offered | Shares bid for | Subscribed |
|---|---|---|---|
| Qualified Institutional Buyers (QIB) | 11,40,000 | 12,30,000 | 1.08x |
| Non-Institutional Investors (NII) | 11,58,000 | 20,02,000 | 1.73x |
| bNII — bids above ₹10 Lakh | 5,72,000 | 16,32,000 | 2.85x |
| sNII — bids ₹2 Lakh to ₹10 Lakh | 2,86,000 | 3,70,000 | 1.29x |
| Retail Individual Investors (RII) | 19,96,000 | 32,32,000 | 1.62x |
| Total | 42,94,000 | 64,64,000 | 1.51x |
Financials
- P/E Ratio
- 15.52
- EPS (₹)
- 4.51
- RoCE
- 17.03%
- RoNW
- 14.74%
- PAT Margin
- 9.30%
Separate pre- and post-issue P/E are not available for this IPO; the P/E shown is as disclosed for the issue.
| Period ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 104.58 | 99.29 | 89.97 | 92.14 |
| Total Income | 42.75 | 77.90 | 63.63 | 54.90 |
| Profit After Tax | 5.12 | 7.21 | 4.07 | 1.01 |
| EBITDA | 11.65 | 20.52 | 17.98 | 16.38 |
| NET Worth | 53.22 | 48.93 | 43.93 | 34.15 |
| Reserves and Surplus | 40.36 | 35.24 | 29.02 | 18.20 |
| Total Borrowing | 31.64 | 33.58 | 31.39 | 42.95 |
Peer comparison
| Company | Issue size | P/E | RoNW | PAT margin | Subscribed | Listing gain |
|---|---|---|---|---|---|---|
| Hannah Joseph Hospital This IPO | — | 15.52 | 14.74% | 9.30% | 1.51x | -7.14% |
| Accretion Nutraveda SME · listed 4 Feb 2026 | — | 20.02 | 48.85% | 16.33% | 1.77x | +48.06% |
| KRM Ayurveda SME · listed 27 Jan 2026 | — | 23.73 | 67.86% | 15.80% | 74.43x | +27.48% |
| Modern Diagnostic & Research Centre SME · listed 7 Jan 2026 | — | 11.33 | 43.27% | 11.51% | 350.49x | 0.00% |
| Goldline Pharmaceutical SME · listed 19 May 2026 | ₹12 Cr | 13.93 | 27.37% | 10.09% | 781.85x | +38.95% |
| Himalaya Nutravedics India SME · listed 29 Sep 2026 | ₹26.5 Cr | 12.63 | 45.12% | 17.16% | 2.24x | +11.32% |
| Speciality Medicines SME · listed 30 Mar 2026 | ₹29 Cr | 10.49 | 28.30% | 14.77% | 2.19x | 0.00% |
Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.
IPO objectives
How Hannah Joseph Hospital plans to use the money raised, as stated in the offer document.
- Funding of capital expenditure for establishing Radiation Oncology Centre ₹34.98 Cr
- General Corporate Purpose₹0.32 Cr
About Hannah Joseph Hospital
Hannah Joseph Hospital is a healthcare institution established with the aim of delivering quality medical services across multiple specialties. Over the years, the hospital has built a reputation for patient-centric care, supported by modern infrastructure and a team of qualified doctors and medical professionals. Its history reflects steady growth in terms of facilities, service offerings, and outreach within its region. The hospital provides a range of healthcare services including general medicine, diagnostics, emergency care, and specialised treatments. Promoted by experienced professionals in the healthcare sector, its business model focuses on offering affordable and accessible treatment while maintaining clinical standards. Revenue is primarily generated through consultations, procedures, and diagnostic services, with a strong emphasis on expanding patient base and service capabilities.
Promoters and shareholding
Arunkumar Nalina, Fenn Kavitha Fenn Arunkumar, Mosesjoseph Arunkumar and Noyel Arunkumar
- Promoter holding, pre-issue
- 93.57%
- Promoter holding, post-issue
- 68.83%
Registrar, lead managers and documents
Lead manager
Company contact
134, Lake View Road, K.K.Nagar, Madurai, Tamil Nadu, 625020
9524729594
cs@hannahjosephhospital.comHannah Joseph Hospital IPO: common questions
1.When does the Hannah Joseph Hospital IPO open and close?
The Hannah Joseph Hospital IPO opens on 22 Jan 2026 and closes on 27 Jan 2026.
2.What is the price band of the Hannah Joseph Hospital IPO?
The price band is ₹67 – ₹70 per share, with a lot size of 1,500 shares and a minimum investment of ₹1,05,000.
3.What is the GMP of the Hannah Joseph Hospital IPO?
The last reported grey market premium is ₹2 per share as of 01 Feb 2026, 10:14 AM IST. GMP is unofficial and changes frequently.
4.When is the Hannah Joseph Hospital IPO allotment?
The basis of allotment is expected on 29 Jan 2026. Allotment status can be checked with the registrar, Bigshare Services Private Limited.
5.When will the Hannah Joseph Hospital IPO list?
The shares listed on 1 Feb 2026 on BSE SME.
6.Who is the lead manager of the Hannah Joseph Hospital IPO?
The book running lead manager is Capital Square Advisors Pvt. Ltd., and the registrar is Bigshare Services Private Limited.
7.What will the money raised in the Hannah Joseph Hospital IPO be used for?
As stated in the offer document, the proceeds are for: Funding of capital expenditure for establishing Radiation Oncology Centre ; General Corporate Purpose.
8.How can my company launch an IPO like Hannah Joseph Hospital?
Start with an IPO readiness assessment: eligibility for the NSE Emerge or BSE SME platform, audited financials, governance, conversion to a public limited company and an indicative valuation. Be IPO Ready advises promoters through each step, from readiness to listing day.
For business owners
Your company could be the next listing
Businesses like these raise growth capital on the public markets every week. Tell us about yours and our advisors will tell you, plainly, whether an IPO is within reach and what it would take.
- Eligibility check against NSE Emerge, BSE SME and Main Board norms
- Indicative valuation and issue size for your business
- A clear timeline from readiness to listing day
Check if your business can list
Fill in the eligibility form and get an assessment of where you stand. It takes about five minutes.
Prefer to talk? Call +91 92130 20393